Allow us, dear customers, to acquaint you with a medicinal marvel: the Budecort 200 Inhaler.
Asthama
Budecort Inhaler 200 mcg (200 mdi)
$18.00 – $81.96
Generic For: Pulmicort Inhaler
Generic Name: Budesonide
Ingredients
This potent pharmaceutical preparation comprises the active ingredient Budesonide, a glucocorticoid steroid that possesses formidable anti-inflammatory properties. As you can see, the Budecort 200 Inhaler is a powerful tool in the arsenal against respiratory illnesses. With its active ingredient Budesonide, this inhaler can alleviate the symptoms of asthma and COPD, improve lung function, and enhance the overall quality of life for those who suffer from these debilitating conditions.
Product
The Budecort Inhaler is an aerosol inhaler that is designed to deliver this beneficial compound directly to the respiratory system. It is formulated to treat asthma and chronic obstructive pulmonary disease (COPD), both of which afflict millions of individuals worldwide and can significantly impact their quality of life. Inhaling Budesonide through the Budecort 200 Inhaler can reduce inflammation in the lungs, airways, and nasal passages, thus alleviating symptoms like coughing, wheezing, and shortness of breath. Moreover, this medication can help prevent the onset of asthma attacks and COPD exacerbations, which can be life-threatening events.
Usage
Shake the inhaler well before use, Breathe out completely, Hold the inhaler upright and place it in your mouth, Press down on the canister to release the medication while inhaling deeply, Hold your breath for 10 seconds( if possible only) then exhale slowly. Wait for 1-2 minutes before using again, if needed. You must Consult your doctor to know properly about the usage. You can check the pack of inhaler too for instructions.
The Budecort 200 Inhaler is easy to use and has a rapid onset of action. Its safety profile is well-established, and it has been extensively studied and tested.
Manufacturer
This great product is manufactured by Cipla Ltd.
Reviews
There are no reviews yet.